Therapeutic targeting of brain bioenergetics in Alzheimer's disease addressing insulin resistance, glucose hypometabolism, and mitochondrial dysfunction.

Copy APA Copied ✓ Copy MLA Copied ✓ Copy BibTeX Copied ✓